The independent platform for news, articles and advice for professionals in laboratory medicine

Coronavirus antibody test authorisation by Public Health England: comment from BIVDA

The British In Vitro Diagnostics Association (BIVDA) has commented on recent media headlines as testing continues to underpin the fight against the SARS-CoV-2 coronavirus.

The Roche test, which detects antibodies to the virus and could therefore indicate which people have previously been infected, is the latest to achieve CE marking, but the first to have been evaluated by Public Health England (PHE), with a number of other companies who have had CE-marked kits available for a longer period still undergoing evaluation.

The in vitro diagnostics (IVD) industry has been working flat out over the past few months to develop and manufacture tests and reagents for healthcare systems around the world. Initially, this focused on tests to detect actively infected individuals mostly using polymerase chain reaction (PCR) technology from swab samples. The focus has now moved to laboratory-based tests for antibody in blood, while companies are also continuing to refine and improve the lateral-flow technology that would permit antibody testing from a fingerprick sample of blood.

Commenting on the progress made so far, BIVDA Chief Executive Doris-Ann Williams (pictured) said: “The government are in the process of revising their testing strategy to cover the next 9–12 months, and the IVD industry will continue to support in any way possible, but there are questions within the BIVDA membership over apparent preselection of laboratory antibody tests from a small number of companies when others with CE-marked tests have not been selected for evaluation by Public Health England.”

Upcoming Events

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

Interpreting Reports: UK NEQAS Haematology

ONLINE
21st March 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

Interpreting Reports: UK NEQAS Haematology

ONLINE
21st March 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025